[Event Report] The 61st Breakfast Meeting “Medical ICT and related regulations: Case examples from foreign countries and the desired future debate in Japan” (March 24, 2017)
date : 3/24/2017
Tags: Future of the Health Care System, HGPI Seminar, Innovation and Sustainability
At this breakfast meeting, Mr. Takafumi Ochiai (lawyer), gave a lecture entitled “Medical ICT and related regulations: Case examples from foreign countries and the desired future debate in Japan”
Summary of the Event
■Regulations relating to the use of telemedicine
The promotion of telemedicine is part of the national Government’s Growth Strategy, which is being advanced by the Headquarters for Healthcare Policy and other agencies. The August 2015 administrative circular on the proper use of telemedicine from the chief of the Health Policy Bureau was issued in line with this strategy. The issuance of the circular led to the emergence of doctors and businesses willing to offer telemedicine-based services for patients with chronic diseases being treated in urban areas. Up to now, telemedicine has been regulated under article 20 of the Medical Practitioners’ Act. Physicians have previously made use of only a select few telemedicine models related to matters such as diagnostic imaging. However, owing to the aforementioned circular and the impression it conveyed that it was not necessary for a patient’s first consultation to be done in a face-to-face setting, trends toward the promotion of telemedicine are gaining momentum even in places other than remote localities and outlying islands. In terms of related regulations, there are some cases in which problems are arising pertaining to the Medical Service Act and other regulations, in addition to the Medical Practitioners’ Act.
■ Reimbursements relating to the use of telemedicine
With regard to reimbursements for medical services that make use of telemedicine, in cases where doctors are working with other doctors through teleconferencing, the assisting doctors only receive reimbursements for their services in limited instances, such as when they perform diagnostic imaging. However, in doctor-to-patient cases, telemedicine reimbursements are provided in line with what they would be for face-to-face consultations. In cases where a patient’s first ever consultation with a doctor is performed via telemedicine, patients are not charged any special “first consultation” fees. Moving forward, the Central Social Insurance Medical Council will be examining ways to account for lost “first consultation” fees when calculating the amount of reimbursement in instances where telemedicine is used.
■ Important matters with regard to laws and regulations related to medical services
Medical devices are regulated by the Pharmaceuticals and Medical Devices Act. The extant of this law’s purview is large however, and the actual scope of its applicability may lead to problems when put into practice. It is therefore all the more important to pay heed to the Pharmacist Act, the Pharmaceuticals and Medical Devices Act, and other relevant regulations when prescribing and forwarding medical and pharmaceutical products.
■Regarding the utilization of medical information, data portability, etc.
The revision of the Personal Information Protection Act has clarified the definition of personal information, and has added provisions giving considerable consideration to personal information. Much discussions is now underway regarding the utilization of Big Data and anonymous data information processing in the medical field. The most recent revision of the Act included the formulation of guidelines for the medical field from the perspective of reinforcing the protection of personal information without creating impediments to the practice of medicine. Lawmakers are now working to formulate new research ethics guidelines, lay the foundation for the next generation of medical law separate from the Personal Information Protection Act, and promote the further use of information. Furthermore, we are entering the era in which consumers will be managing and utilizing their own personal information (as can be seen in the discussions people are having related to data portability rights in relation to the European General Data Protection Regulation). Personal Data Stores (PDS), information banks, data transaction markets and other issues are being investigated by the Cabinet Secretariat.
In addition to the above, Mr. Ochiai also provided explanations on data circulation and utilization, and on the revision of existing laws related to data and the course of action for the improvement of future systems. The lecture was followed by a lively Q&A session.
Exhibition date:2017-03-24
Top Research & Recommendations Posts
- [Policy Recommendations] Joint Statement “Protecting the Health of Both the Planet and People — A Japan-Model Planetary Health Strategy to Turn the Climate Crisis into an Opportunity for Health, the Economy, and Growth” (June 24, 2026)
- [Research Report] Energy Conservation and Greenhouse Gas Emissions Reduction in Healthcare Facilities: Case Studies from New Construction and Facility Renewal (March 16, 2026)
- [Recommendations] Strengthening Epidemiology Education in the Veterinary Field for the One Health Era (June 19, 2026)
- [Activity Report] HGPI Contributed to the Development of the Civil 7 (C7) Global Health Working Group’s Climate and Health Thematic Brief for the G7 (June 25, 2026)
- [Research Report] AMR Policy Update #6: The New Global Action Plan on AMR (Part 1)
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Research Report] AMR Policy Update #8: Fostering AMR-Conscious Youth: The Antibiotic Smart Sweden Certificate Program and its Implications for Early Childhood Education (July 1, 2026)
- [Research Report] Perceptions, Knowledge, Actions and Perspectives of Healthcare Organizations in Japan in Relation to Climate Change and Health: A Cross-Sectional Study (November 13, 2025)
- [Announcement] HGPI Joins the UHC2030 Task Force for the 2027 UN High-Level Meeting on UHC (July 6, 2026)
- [Research Report] AMR Policy Update #7: The New Global Action Plan on AMR (Part 2)
Featured Posts
-
2026-06-19
[Recommendations] Strengthening Epidemiology Education in the Veterinary Field for the One Health Era (June 19, 2026)
-
2026-07-02
[Research Report] Medical Practitioner Interviews on the Current State and Issues for Interdepartmental Collaboration in Clinical Practice for Chronic Kidney Disease (June 30, 2026)
-
2026-07-21
[Announcement] Announcement of the 2nd Kiyoshi Kurokawa Award Recipient
-
2026-07-22
[Registration Open] Second Session of the Planetary Health Academy (Starts September 2026)



